We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Files for Patent Office Review of Three Biogen Claims for Rituxan
Pfizer Files for Patent Office Review of Three Biogen Claims for Rituxan
Pfizer called for the invalidation of three Rituxan patents covering treatments for non-Hodgkin lymphomas last week, filing separate complaints with the PTO’s patent review board.